Progression of macular ischemia following intravitreal bevacizumab.
作者： E. Jason Sabet-Peyman , Florian M. A. Heussen , Jennifer E. Thorne , Heather Casparis , Sayjal J. Patel
DOI: 10.3928/15428877-20090430-17
关键词:
摘要: A 37-year-old woman with bilateral obliterative retinal vasculitis and macular ischemia received intravitreal bevacizumab for rapidly progressive neovascularization of the optic disc vitreous hemorrhage in left eye. One week after treatment, she presented central scotoma fluorescein angiography revealed increased parafoveal capillary dropout treated
elsevier.com
sci-hub.st 参考文章(9)
Changes in Retinal Neovascularization after Pegaptanib (Macugen) Therapy in Diabetic Individuals Ophthalmology. ,vol. 113, pp. 23- 28 ,(2006) , 10.1016/J.OPHTHA.2005.10.012
Yuji Oshima, Sachiko Oshima, Hiroyuki Nambu, Shu Kachi, Kyoichi Takahashi, Naoyasu Umeda, Jikui Shen, Aling Dong, Rajendra S. Apte, Elia Duh, Sean F. Hackett, Godwin Okoye, Kazuki Ishibashi, James Handa, Michele Melia, Stanley Wiegand, George Yancopoulos, Donald J. Zack, Peter A. Campochiaro, Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive The FASEB Journal. ,vol. 19, pp. 963- 965 ,(2005) , 10.1096/FJ.04-2209FJE
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology. ,vol. 112, pp. 1747- 1757 ,(2005) , 10.1016/J.OPHTHA.2005.06.007
Tsontcho Ianchulev, Naveed Shams, Role of vascular endothelial growth factor in ocular angiogenesis. Ophthalmology Clinics of North America. ,vol. 19, pp. 335- 344 ,(2006) , 10.1016/J.OHC.2006.05.005
Ron Margolis, Careen Y. Lowder, Jonathan E. Sears, Peter K. Kaiser, Intravitreal bevacizumab for macular edema due to occlusive vasculitis. Seminars in Ophthalmology. ,vol. 22, pp. 105- 108 ,(2007) , 10.1080/08820530701420074
FREDERICK H. DAVIDORF, J GARRET MOUSER, ROBERT J. DERICK, Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 26, pp. 354- 356 ,(2006) , 10.1097/00006982-200603000-00017
JOHN O. MASON, MICHAEL A. ALBERT, RACHEL VAIL, Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 26, pp. 356- 357 ,(2006) , 10.1097/00006982-200603000-00018
ROBERT L. AVERY, Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 26, pp. 352- 354 ,(2006) , 10.1097/00006982-200603000-00016
Susumu Ishida, Tomohiko Usui, Kenji Yamashiro, Yuichi Kaji, Ednan Ahmed, Karen G. Carrasquillo, Shiro Amano, Tetsuo Hida, Yoshihisa Oguchi, Anthony P. Adamis, VEGF164 is proinflammatory in the diabetic retina. Investigative Ophthalmology & Visual Science. ,vol. 44, pp. 2155- 2162 ,(2003) , 10.1167/IOVS.02-0807